Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1
- PMID: 3501941
- PMCID: PMC175819
- DOI: 10.1128/AAC.31.12.1879
Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1
Abstract
The antiviral activities of various dideoxynucleosides against LAV strains of human immunodeficiency viruses type 1 (HIV-1) and type 2 (HIV-2) were evaluated. Significantly more 3'-azido-3'-deoxythymidine was required to inhibit the replication of HIV-2 than HIV-1 in three human cell lines. HIV-2 also appeared more resistant than HIV-1 to other dideoxynucleosides. These results suggest that dideoxynucleosides may be less effective in vivo for HIV-2 infection and that a broader range of clinical isolates of human retroviruses should be examined for drug susceptibility in vitro.
Similar articles
-
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.Antimicrob Agents Chemother. 1987 Jun;31(6):907-10. doi: 10.1128/AAC.31.6.907. Antimicrob Agents Chemother. 1987. PMID: 3039911 Free PMC article.
-
Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.Antimicrob Agents Chemother. 1990 Jun;34(6):1297-300. doi: 10.1128/AAC.34.6.1297. Antimicrob Agents Chemother. 1990. PMID: 2393292 Free PMC article.
-
Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.AIDS Res Hum Retroviruses. 1988 Apr;4(2):107-13. doi: 10.1089/aid.1988.4.107. AIDS Res Hum Retroviruses. 1988. PMID: 2835072
-
Spectrum of antiviral activity and mechanism of action of zidovudine. An overview.Am J Med. 1988 Aug 29;85(2A):176-81. Am J Med. 1988. PMID: 3044082 Review.
-
Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.Am J Med. 1990 May 21;88(5B):8S-10S. doi: 10.1016/0002-9343(90)90414-9. Am J Med. 1990. PMID: 2186629 Review.
Cited by
-
An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014.Acta Pharm Sin B. 2015 Nov;5(6):520-43. doi: 10.1016/j.apsb.2015.09.001. Epub 2015 Nov 2. Acta Pharm Sin B. 2015. PMID: 26713268 Free PMC article. Review. No abstract available.
-
Human immunodeficiency virus type 2.CMAJ. 1989 Jan 15;140(2):121-2. CMAJ. 1989. PMID: 2910395 Free PMC article. No abstract available.
-
Antiretroviral drug resistance in human immunodeficiency virus type 2.Antimicrob Agents Chemother. 2009 Sep;53(9):3611-9. doi: 10.1128/AAC.00154-09. Epub 2009 May 26. Antimicrob Agents Chemother. 2009. PMID: 19470514 Free PMC article. Review. No abstract available.
-
Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine.Antimicrob Agents Chemother. 1989 Jan;33(1):53-7. doi: 10.1128/AAC.33.1.53. Antimicrob Agents Chemother. 1989. PMID: 2653214 Free PMC article.
-
Antiretroviral therapy: reverse transcriptase inhibition.Antimicrob Agents Chemother. 1992 Feb;36(2):245-54. doi: 10.1128/AAC.36.2.245. Antimicrob Agents Chemother. 1992. PMID: 1376595 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources